Enzon Pharmaceuticals, Inc.
Ticker(s):
ENZN
Country:
Sector & Industry:
Business Overview
Enzon Pharmaceuticals, Inc., together with its subsidiaries, does not have significant operations. Previously, it sells its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.
Contact & Other Information
Number of Employees:
Website:
,
,
Enzon Pharmaceuticals is operating as an acquisition vehicle, aiming to utilize its net operating loss carryforwards (NOLs). The company is financially stable with a significant cash reserve, but faces risks related to acquisitions and NOL utilization.